Accessibility Menu

Novacyt(FRA) NYZ

Market Cap€34.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€0.48
+3.00%
+0.01Today

Novacyt Financials at a Glance

Market Cap

€34.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

-€0.38

P/E Ratio

-1.28

Dividend

€0.00

Beta (Volatility)

-0.11 (Low)

Price

€0.48

Volume

0

Open

€0.49

Previous Close

€0.48

Daily Range

€0.48 - €0.49

52-Week Range

€0.29 - €0.97

Estimated Earnings Date

N/A

NYZ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novacyt

Novacyt SAS engages in the development and sale of cancer and infectious disease diagnostic products. It operates through the Corporate and Diagnostics; and Molecular Products segments. The Corporate and Diagnostics segment includes diagnostic activities in laboratories, and the manufacturing and distribution of reagents and kits for bacterial and blood tests. The Molecular Products segment comprises of design, manufacture, and distribution of test kits for certain diseases in humans, animals and food products. The company was founded by Eric Peltier, Gerald Ulrich, and Jean-Pierre Crinelli on July 3, 2006 and is headquartered in Velizy-Villacoublay, France.

Industry

Biotechnology

Sector

Health Care

CEO

Lyn Dafydd Rees

Website

www.novacyt.com

NYZ Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-64.24%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-78.13%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€34.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

72.59M

Volume

0

Avg. Volume

90.909

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Novacyt Performance Analysis

Novacyt annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 24,659,646-77.1%
20232023-12-31EUR 12,211,880-50.5%
20242024-12-31EUR 23,189,11989.9%
20252025-12-31EUR 23,388,7470.9%
Novacyt annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR -0.43166.4%
20232023-12-31EUR -0.467.9%
20242024-12-31EUR -0.7051.6%
20252025-12-31EUR -0.38-45.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

€34.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About NYZ

What is the current price of Novacyt?

Novacyt is trading at €0.48 per share.

What is the 52-week range for Novacyt?

Over the past 52 weeks, Novacyt has traded between €0.29 and €0.97.

How much debt does Novacyt have?

As of the most recent reporting period, Novacyt reported total debt of €11.97M.

How much cash does Novacyt have on hand?

Novacyt reported €21.93M in cash and cash equivalents in its most recent financial results.

What is Novacyt’s dividend yield?

Novacyt does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services